So. what are the most common antiarrhythmic drugs? Let’s start with the basics
Antiarrhythmics are medications that prevent and treat a heart rhythm that is too fast or irregular also known as arrhythmias. Arrhythmia involves a problem with your heart’s electrical system. Your heart may beat too quickly, too slowly or erratically (irregularly). Antiarrhythmics treat abnormal heart rhythms including atrial fibrillation, atrial flutter, ventricular tachycardia or ventricular fibrillation.
In general, antiarrhythmics reset your heart to a normal rhythm or prevent episodes of arrhythmia. They act on the heart’s various electrical channels (see below) to:
There are several classes of antiarrhythmics. Each class works in a different way, depending on the type of arrhythmia and its cause.
Most arrhythmia medications are taken by mouth over a long period of time for lasting treatment. Some are delivered intravenously (injected into the bloodstream) for patients who are unstable or cannot take oral medications.
There are several types of arrhythmia treatments, including:
Your doctor will recommend treatment depending on the type of arrhythmia you have and how serious it is. They may recommend antiarrhythmic medications if arrhythmia:
There are four classes of antiarrhythmics, based on the Vaughan-Williams (VW) classification system:
Other antiarrhythmic drugs not included in the VW classification system include:
Adenosine. This medication can block or slow down electrical impulses at the atrioventricular node (AVN), between the upper and lower chambers of the heart.
Digoxin. This drug slows the heart rate and make it contracts more strongly.
Arrhythmia treatment also may involve other medications that are not antiarrhythmics, such as anticoagulants (blood thinners).
Antiarrhythmics are often very effective. But it may take several tries to find the medication and dose that works best for you depending on efficacy and tolerability.
We have described what are the most common antiarrhythmic drugs. We hope it has been helpful.
This is a good review article: King, 2023.